Neue Therapien akuter und chronischer Beckenvenenobstruktionen

Zusammenfassung

Die Inzidenz der tiefen Venenthrombose (TVT) beträgt in Westeuropa 1/1000 Einwohner pro Jahr. Je nach Lokalisation und Ausdehnung der TVT entwickeln 20–83% der Patienten ein postthrombotisches Syndrom trotz einer optimalen Antikoagulation und Kompressionstherapie. Endovaskuläre Thrombektomieverfahren mit Wiedereröffnung der iliofemoralen venösen Strombahn haben das Ziel, mittel- und langfristig ein postthrombotisches Syndrom zu vermeiden. Bei Patienten mit chronischen V.-cava- und Beckenvenenverschlüssen stehen heutzutage spezielle Rekanalisationstechniken mit Einsatz von speziellen venösen Stents zur Verfügung.

Abstract

Deep vein thrombosis (DVT) is associated with a high cost burden for health care systems because of secondary cost intensive complications like pulmonary embolism and especially the post thrombotic syndrome (PTS). Current standard therapy of anticoagulation for DVT therapy has not changed through the years leaving patients especially with iliofemoral vein thrombus on a high-risk situation for developing PTS. For patients with chronic venous outflow obstruction of the iliac vein system dedicated venous stents and recanalization techniques are today available.

Was ist wichtig?

• Je nach Lokalisation und Ausdehnung der tiefen Venenthrombose entwickeln 20–83% der Patienten ein postthrombotisches Syndrom trotz optimaler Antikoagulation und Kompressionstherapie.

• Endovaskuläre Thrombektomieverfahren mit Wiedereröffnung der iliofemoralen venösen Strombahn haben das Ziel, mittel- und langfristig ein postthrombotisches Syndrom zu vermeiden.

• Bei Patienten mit chronischen V.-cava- und Beckenvenenverschlüssen stehen heutzutage spezielle endovaskuläre Rekanalisationstechniken mit Einsatz von venösen Stents zur Verfügung, die mit höherer Radialkraft und verbesserter Flexibilität den speziellen Anforderungen der Behandlung im venösen System gerecht werden.

Schlüsselwörter

postthrombotisches Syndrom - May-Thurner-Syndrom - venöse Stents

Keywords

May-Thurner syndrome - post thrombotic syndrome - venous stents

Publication History

Article published online:
12 April 2022

• Literatur

• 1 White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107 (Suppl. 01) I4-I8 DOI: 10.1161/01.cir.0000078468.11849.66. (PMID: 31041801)
• 2 Akesson H, Brudin L, Dahlstrom JA. et al. Venous function assessed during a 5 year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 1990; 4: 43-48 DOI: 10.1016/s0950-821x(05)80037-4. (PMID: 2323420)
• 3 Cogo A, Lensing AW, Prandoni P. et al. Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. Arch Intern Med 1993; 153: 2777-2780 (PMID: 8257253)
• 4 Plate G, Akesson H, Einarsson E. et al. Long-term results of venous thrombectomy combined with a temporary arterio-venous fistula. Eur J Vasc Surg 1990; 4: 483-489 DOI: 10.1016/s0950-821x(05)80788-1. (PMID: 2226879)
• 5 Kahn SR, Shapiro S, Wells PS. et al. Compression stockings to prevent postthrombotic syndrome: a randomized placebo-controlled trial. Lancet 2014; 383: 880-888 DOI: 10.1016/S0140-6736(13)61902-9. (PMID: 24315521)
• 6 Stevens SM, Woller SC, Baumann Kreuziger L. et al. Executive Summary: Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report. Chest 2021; 160: 2247-2259
• 7 AWMF. S2k-Leitlinie Venenthrombose und Lungenembolie: Diagnostik und Therapie. AWMF-Register-Nr. 065–002. 10.10.2015 Accessed February 03, 2022 at: https://www.awmf.org/leitlinien/detail/ll/065–002.html
• 8 Meissner M, Gloviczki P, Comerota A. et al. Early thrombus removal strategies for acute deep venous thrombosis: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012; 55: 1449-1462 DOI: 10.1016/j.jvs.2011.12.081. (PMID: 22469503)
• 9 Virchow R. Über die Erweiterung kleiner Gefäße. Arch Path Anat 1851; 3: 427
• 10 May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology 1957; 8: 419-427 DOI: 10.1177/000331975700800505. (PMID: 13478912)
• 11 Cockett FB, Thomas ML. The iliac compression syndrome. Br J Surg 1965; 52: 816-821 DOI: 10.1002/bjs.1800521028. (PMID: 5828716)
• 12 Oguzkurt L, Ozkan U, Ulusuan S. et al. Compression of the left common iliac vein in asymptomatic subjects and patients with left iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2008; 19: 366-370
• 13 Chung JW, Yoon CJ, Jung SI. et al. Acute iliofemoral deep vein thrombosis: evaluation of underlying anatomic abnormalities by spiral CT venography. J Vasc Interv Radiol 2004; 15: 249-256 DOI: 10.1097/01.rvi.0000109402.52762.8d. (PMID: 15028809)
• 14 Fraser DG, Moody AR, Martel A. et al. Re-evaluation of iliac compression syndrome using magnetic resonance imaging in patients with acute deep venous thromboses. J Vasc Surg 2004; 40: 604-661 DOI: 10.1016/j.jvs.2004.07.039. (PMID: 15472584)
• 15 McDermott S, Oliveira G, Ergül E. et al. May-Thurner syndrome: can it be diagnosed by a single MR venography study?. Diagn Interv Radiol 2013; 19: 44-48 DOI: 10.4261/1305-3825.DIR.5939-12.1. (PMID: 22801870)
• 16 Arnoldussen CWKP, de Graaf R, Wittens CHA. et al. Value of magnetic resonance venography and computed tomographic venography in lower extremity chronic venous disease. Phlebology 2013; 28 (Suppl. 01) 169-175
• 17 Black S. VIVA conference 2016, 18–22 September 2016. Las Vegas: oral presentation
• 18 Gagne PJ, Tahara RW, Fastabend CP. et al. Venography versus intravascular ultrasound for diagnosing and treating iliofemoral vein obstruction. J Vasc Surg Venous Lymphat Disord 2017; 5: 678-687 DOI: 10.1016/j.jvsv.2017.04.007. (PMID: 28818221)
• 19 de Graaf R, Arnoldussen CWKP, Wittens CHA. Stenting for chronic venous obstructions a new era. Phlebology 2013; 28 (Suppl. 01) 117-122
• 20 de Wolf MA, de Graaf R, Kurstjens RL. et al. Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous Stent. Eur J Vasc Endovasc Surg 2015; 50: 518-526 DOI: 10.1016/j.ejvs.2015.05.011. (PMID: 26187656)
• 21 O’Sullivan GJ, Karunanithy N, Binkert CA. et al. One Year Outcomes of the VIVO-EU Study of Treatment of Symptomatic Iliofemoral Outflow Obstruction with the Zilver Vena Venous Self-Expanding Stent. Cardiovasc Intervent Radiol 2021; 44: 1930-1936 DOI: 10.1007/s00270-021-02969-0. (PMID: 34611732)
• 22 de Wolf MA, de Graaf R, Kurstjens RL. et al. Short-Term Clinical Experience with a Dedicated Venous Nitinol Stent: Initial Results with the Sinus-Venous Stent. Eur J Vasc Endovasc Surg 2015; 50: 518-526 DOI: 10.1016/j.ejvs.2015.05.011. (PMID: 26187656)
• 23 Lichtenberg M, Breuckmann F, Stahlhoff WF. et al. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions – short-term safety, patency, and clinical outcomes. Vasa 2018; 47: 475-481 DOI: 10.1024/0301-1526/a000731. (PMID: 30175948)
• 24 Razavi MK, Black S, Gagne P. et al. Pivotal Study of Endovenous Stent Placement for Symptomatic Iliofemoral Venous Obstruction. Circ Cardiovasc Interv 2019; 12: e008268 DOI: 10.1161/CIRCINTERVENTIONS.119.008268. (PMID: 31833414)
• 25 Dake MD, O’Sullivan G, Shammas NW. et al. Three-Year Results from the Venovo Venous Stent Study for the Treatment of Iliac and Femoral Vein Obstruction. Cardiovasc Intervent Radiol 2021; 44: 1918-1929 DOI: 10.1007/s00270-021-02975-2. (PMID: 34545448)
• 26 Lichtenberg M, Stahlhoff S, Özkapi A. et al. Braided nitinol stent for chronic iliofemoral venous disease – the real-world BLUEFLOW registry. Vasa 2021; 50: 372-377 DOI: 10.1024/0301-1526/a000953. (PMID: 33955794)
• 27 de Graaf R, de Wolf M, Sailer AM. et al. Iliocaval confluence stenting for chronic venous obstructions. Cardiovasc Intervent Radiol 2015; 38: 1198-1204 DOI: 10.1007/s00270-015-1068-5. (PMID: 25772400)
• 28 Jalaie H, Arnoldussen CWKP, Barbati M. et al. What predicts outcome after recanalization of chronic venous obstruction: hemodynamic factors, stent geometry, patient selection, anticoagulation or other factors?. Phlebology 2014; 29 (Suppl. 01) 97-103 DOI: 10.1177/0268355514529510. (PMID: 24843094)